Investment adviser · CRD 163726

ABV, LLC

Exempt reporting adviser (ERA)

Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.

NEW YORK, NY, United States · Form ADV filed Mar 30, 2022

Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →

Private funds & service providers

7 Private funds

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

ASCENT BIOMEDICAL VENTURES II, L.P.Venture Capital Fund · Last reported Mar 30, 2022$36.7MGross asset value
Fund administrator GEN II FUND SERVICES NEW YORK, New York, United States Investor statements: Some (provided to some but not all investors) Related to adviser: No
Auditor RSM US, LLP NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
Yes
External marketing
No

RSM US, LLP
PCAOB 49

Fund details & source
Fund ID
805-9222403026
Reported beneficial owners
53
Minimum commitment
$250K

Form ADV 1635891 · Mar 30, 2022 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ASCENT BIOMEDICAL VENTURES I, L.P.Venture Capital Fund · Last reported Mar 30, 2022$25.3MGross asset value
Auditor RSM US, LLP NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

RSM US, LLP
PCAOB 49

Fund details & source
Fund ID
805-8031432479
Reported beneficial owners
84
Minimum commitment
$250K

Form ADV 1635891 · Mar 30, 2022 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ASCENT BIOMEDICAL VENTURES II NY, L.P.Venture Capital Fund · Last reported Mar 30, 2022$17.4MGross asset value
Auditor RSM US, LLP NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

RSM US, LLP
PCAOB 49

Fund details & source
Fund ID
805-1280716785
Reported beneficial owners
2
Minimum commitment
$250K

Form ADV 1635891 · Mar 30, 2022 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ASCENT BIOMEDICAL VENTURES I ANNEX, L.P.Venture Capital Fund · Last reported Mar 30, 2022$17.4MGross asset value
Auditor RSM US, LLP NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

RSM US, LLP
PCAOB 49

Fund details & source
Fund ID
805-2441755984
Reported beneficial owners
31
Minimum commitment
$25K

Form ADV 1635891 · Mar 30, 2022 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ASCENT BIOMEDICAL VENTURES SYNECOR, L.P.Venture Capital Fund · Last reported Mar 30, 2022$7.45MGross asset value

Feeder funds

  • ABVS FUND (CAYMAN), LTD.
Auditor RSM US, LLP NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

RSM US, LLP
PCAOB 49

Fund details & source
Fund ID
805-3821259265
Reported beneficial owners
36
Minimum commitment
$250K

Form ADV 1635891 · Mar 30, 2022 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ASCENT BIOMEDICAL HOLDINGS, L.P.Other Private Fund · Last reported Mar 30, 2022$6.98MGross asset value
Auditor COHN REZNICK NEW YORK, New York, United States
Custodian JEFFRIES & COMPANY, INC. NEW YORK, New York, United States Related to adviser: No
Prime broker JEFFRIES & COMPANY, INC. NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

COHN REZNICK
PCAOB 596

Fund details & source
Fund ID
805-4522241052
Reported beneficial owners
6
Minimum commitment
$250K

Form ADV 1635891 · Mar 30, 2022 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ASCENT BIOMEDICAL VENTURES I NY, L.P.Venture Capital Fund · Last reported Mar 30, 2022$4.81MGross asset value
Auditor RSM US, LLP NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

RSM US, LLP
PCAOB 49

Fund details & source
Fund ID
805-7959522259
Reported beneficial owners
2
Minimum commitment
$250K

Form ADV 1635891 · Mar 30, 2022 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Mar 30, 2022. View historical filings

Reported services

Not reported in these imported fields

Compensation

Not reported in these imported fields

Principal office

1 ROCKEFELLERPLAZA, SUITE 1040
NEW YORK, NY, 10020, United States

CRD 163726

Filing source

Form ADV 1635891 · Mar 30, 2022 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.